(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry-Reference-Cited by-同舟云学术

(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

Published:2012-02-23 Issue:3 Volume:55 Page:720-729
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Calland Noémie,Albecka Anna,Belouzard Sandrine,Wychowski Czeslaw,Duverlie Gilles,Descamps Véronique,Hober Didier,Dubuisson Jean,Rouillé Yves,Séron Karin

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24803/fullpdf

Reference37 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Treating viral hepatitis C: efficacy, side effects, and complications;Manns;Gut,2006

3. New direct-acting antivirals' combination for the treatment of chronic hepatitis C;Asselah;Liver Int,2011

4. Resistance to direct antiviral agents in patients with hepatitis C virus infection;Sarrazin;Gastroenterology,2010

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Envelope Protein-Targeting Zika Virus Entry Inhibitors;International Journal of Molecular Sciences;2024-08-30

2. Green tea extract reduces viral proliferation and ROS production during Feline Herpesvirus type-1 (FHV-1) infection;BMC Veterinary Research;2024-08-22

3. Exploring the Antiviral Potential of Polyphenols against Re-emerging and Emerging Viral Infections: A Comprehensive Review;Journal of Natural Remedies;2024-07-31

4. Targeting SARS-CoV-2 Spike and Main protease with phytochemicals from Herbs and spices: Molecular Docking and dynamics simulation studies.;Journal of Physics: Conference Series;2024-07-01

5. Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates;2024-06-28